Abstract| Volume 37, 101535, January 2020

Neuromyelitis Optica: A Pilot Study of Clinical Presentation and Status of Serological BiomarkersNMOIgG, AQP4 Among Patients Admitted to a Tertiary Centre in NCNS Sudan

      Neuromyelitis optica (NMO)is one of the demylinating diseases affecting mainly the optic nerves and spinal cord. The disease is distinguished from other demyelinating conditions by the presence of NMO IgG and serum AQP4, which is expressed as AQP4 gene and found mainly in the blood brain barriers of the brain and spinal cord.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Multiple Sclerosis and Related Disorders
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect